5-HTP, Serotonin, and Mood: Understanding the Pathways

5-hydroxytryptophan, or 5-HTP, is the chemical intermediate between the amino acid tryptophan and the neurotransmitter serotonin — the molecule the brain extracts from your diet to make serotonin once it crosses the blood–brain barrier. Because of that direct precursor role, 5-HTP has been studied for decades as a possible nutritional lever for mood. The evidence base is real but uneven: some older trials are promising, the broader serotonin-deficiency model of depression has been seriously challenged, and a small 2025 trial has put 5-HTP back on the radar. This guide walks through the pathway biology, the honest state of the evidence, the practical dosing science, and where 5-HTP actually fits in a modern mood-support toolkit.

What is 5-HTP and where does it come from?

5-HTP is 5-hydroxytryptophan, the molecule that sits halfway between the dietary amino acid tryptophan and the neurotransmitter serotonin (5-hydroxytryptamine). It is not present in any meaningful quantity in food. Commercial 5-HTP supplements are extracted from the seeds of Griffonia simplicifolia, a climbing legume native to West Africa whose seeds typically contain around 6–14% 5-HTP by weight, with some reports of concentrations up to roughly 20%.⁴

That precursor role is the entire scientific case for 5-HTP. Your body makes its own 5-HTP from tryptophan via the enzyme tryptophan hydroxylase, but that step is the rate-limiting one in the serotonin pathway — meaning the supply of 5-HTP often constrains how much serotonin is produced. Think of tryptophan hydroxylase as a narrow funnel — no matter how much tryptophan is at the top, only so much can make it through to become serotonin. Supplementing with 5-HTP attempts to step around that funnel.

Worth being honest up front: the fact that 5-HTP is a serotonin precursor does not automatically mean taking it will lift mood. Whether it does, in whom, and to what extent, is exactly what the clinical evidence has to answer.

How does 5-HTP become serotonin in the brain?

The serotonin pathway has three biological stops: tryptophan, 5-HTP, then serotonin. Tryptophan, an essential amino acid you obtain from foods like turkey, eggs, dairy, and seeds, is taken up into the brain by an active transporter that it shares with several other large neutral amino acids. Once inside serotonergic neurons — concentrated in the raphe nuclei of the brainstem, which provide most of the brain's serotonin supply — tryptophan is converted to 5-HTP by tryptophan hydroxylase 2 (TPH2), the brain-specific isoform of the rate-limiting enzyme. 5-HTP is then decarboxylated to serotonin by aromatic L-amino acid decarboxylase (AADC), with vitamin B6 (pyridoxal-5-phosphate) as an essential cofactor.^1,6

Two practical details follow from this biology. First, 5-HTP crosses the blood–brain barrier on its own, without needing the shared amino-acid transporter that tryptophan competes for — which is part of why supplemental 5-HTP can raise brain serotonin more efficiently than dietary tryptophan.¹ Second, a substantial proportion of orally administered 5-HTP is converted to serotonin in the peripheral tissues (gut wall, liver, kidneys) before it ever reaches the brain. In clinical research contexts, this is sometimes managed by co-administering carbidopa, a peripheral decarboxylase inhibitor that increases the fraction reaching the central nervous system — but carbidopa is a prescription medicine and is not part of any over-the-counter supplement.¹

Here's what this means in practice: orally taken 5-HTP does raise serum serotonin meaningfully — the 2025 Singapore RCT confirmed this with biomarker measurement³ — but a fraction of that serotonin is acting in the periphery, including in the gut, where roughly 90–95% of the body's serotonin actually resides in enterochromaffin cells.⁷

Is the serotonin theory of depression still considered correct?

This is where intellectual honesty matters. For decades, the dominant explanation for depression was the "serotonin hypothesis" — the idea that low serotonin activity in the brain caused depressive symptoms, and that raising serotonin (with SSRIs or precursors like 5-HTP) corrected the underlying problem. In 2023, a systematic umbrella review published in Molecular Psychiatry (with the online release in mid-2022) examined six lines of evidence for the serotonin theory and concluded that there was no consistent evidence that depression is caused by reduced serotonin activity in the central nervous system.⁸

The review was controversial — multiple research groups have published methodological critiques arguing that the umbrella-review framing misrepresented the strength of certain evidence streams.⁹ The broader picture from the wider neuroscience literature is that the relationship between serotonin and mood is indirect rather than direct. A 2007 meta-analysis of monoamine depletion studies showed that artificially lowering serotonin via acute tryptophan depletion did not reliably worsen mood in healthy people, but did induce depressive symptoms in around 50–60% of patients with depression who were in remission on serotonergic antidepressants (SSRIs/SNRIs) — suggesting that serotonin matters more for vulnerability and response to treatment than as a simple cause-and-effect lever for mood in healthy adults.¹⁰

What does this mean for your decision about 5-HTP? The simple framing — "5-HTP raises serotonin, so it lifts mood" — is too clean. The biology is more conditional. Raising serotonin does seem to influence mood in some people in some contexts, but it is not a universal switch you can simply flip.

What does the clinical evidence say about 5-HTP for mood?

The most-cited clinical evidence for 5-HTP and depression is a 2002 Cochrane review that pooled two small placebo-controlled trials with 64 participants in total. The review found 5-HTP was significantly superior to placebo for depressive symptoms (Peto OR 4.10, 95% CI 1.28–13.15) but explicitly cautioned that the trials available for analysis were small and of insufficient methodological quality to support strong recommendations.² Worth noting: this review is now more than two decades old, and despite the positive signal it generated, large modern replication trials have not followed.

The most recent significant data point comes from a 2025 randomised controlled trial conducted at the National University of Singapore, published in Nutrients. Researchers randomised 30 community-dwelling older adults (mean age 66) to either 100 mg/day of 5-HTP for 12 weeks or no supplementation, under a single-blinded design. The 5-HTP group showed a statistically significant improvement in Montreal Cognitive Assessment (MoCA) scores from baseline to week 12, a reduction in Geriatric Depression Scale scores by week 8, and a significant increase in serum serotonin — which confirmed the supplement was actually reaching its target. Anxiety scores on the Geriatric Anxiety Inventory did not change, and the authors framed the findings as "promising but preliminary," urging larger and longer trials.³

What does the rest of the literature look like if you're trying to weigh this honestly? Older small trials (1970s–1990s) used 5-HTP doses of 200–300 mg per day, often in combination with carbidopa, in patients with treatment-resistant depression — with mixed results and small samples.¹ A consistent picture across the modern literature is that the evidence is suggestive rather than definitive, the trials are mostly small, and 5-HTP has not been tested at the scale and rigour of pharmaceutical antidepressants.

How does 5-HTP compare to tryptophan and to SSRIs?

The three serotonergic options that come up most often in mood discussions sit at different points on the pathway and have very different evidence and regulatory profiles.

The pharmacological distinction matters for how you weigh these options. SSRIs do not increase serotonin synthesis; they slow the reuptake of serotonin that has already been released, raising its concentration in the synapse. 5-HTP and tryptophan act upstream — at the supply side of synthesis — and any effect is mediated by what the body does with the extra raw material once it arrives. That is a meaningfully different mechanism, even if the end-point (a serotonergic intervention) sounds similar.

What dose has been studied, and why is timing important?

Across the modern trials, doses have typically fallen in two bands. The 2025 Singapore RCT used 100 mg per day taken in the evening for 12 weeks.³ Older depression-focused trials used 200–300 mg per day, often divided into three doses with meals.¹ Sleep-focused research has used 100–300 mg taken before bed. Most studied supplement doses are well below the 600 mg/day upper bound used in some historical research.

Why divided dosing? The reason is pharmacokinetic. When you take 5-HTP orally, it has a half-life of roughly 2–4 hours and reaches peak plasma concentration within about 1–2 hours.⁴ A single large dose produces a brief peak followed by a rapid decline. Splitting your total daily dose into two or three smaller doses smooths out the exposure across the day — which matches how your central nervous system actually uses serotonin, in tonic release patterns rather than a single spike.

Vitamin B6 deserves a mention because it is the cofactor for AADC, the enzyme that converts 5-HTP to serotonin. Some 5-HTP products co-formulate with B6 for this reason. Most adults in the UK already obtain adequate B6 from a normal diet, so additional supplementation has limited additive effect — but combined products are reasonable when the dose stays well within recommended B6 limits.

Is 5-HTP safe? What are the real risks?

5-HTP has two distinct safety conversations: drug interactions, which are clinically important and well-characterised, and the historical EMS contamination concern, which deserves careful framing.

Serotonin syndrome risk. Because 5-HTP raises serotonin, combining it with any other agent that increases serotonergic activity creates a risk of serotonin syndrome — a potentially serious clinical condition with symptoms ranging from agitation, tremor, sweating, and diarrhoea at the mild end to hyperthermia, muscle rigidity, and cardiovascular instability at the severe end.⁵ The medications and supplements that should not be combined with 5-HTP without medical supervision include SSRIs (such as sertraline, citalopram, fluoxetine), SNRIs (such as venlafaxine, duloxetine), MAOIs, tricyclic antidepressants, triptan migraine medications, tramadol, pethidine, lithium, and the herbal antidepressant St John's wort. Several other serotonergic agents warrant the same caution: dextromethorphan, which is in many over-the-counter cough remedies; MDMA; the antibiotic linezolid (a reversible MAO inhibitor); and methylene blue. Drug-interaction databases classify these risks as "major" or "serious." If you take any prescription mood medication, opioid analgesic, or migraine treatment — or if you use OTC cough syrup regularly — do not start 5-HTP without speaking to your prescriber or pharmacist.

The EMS history. In 1989, an outbreak of eosinophilia-myalgia syndrome (EMS) affected more than 1,300 people in the US, with at least 38 deaths, and was traced to contaminated L-tryptophan supplements from a single manufacturer (Showa Denko) following changes to its fermentation and purification process. The implicated contaminant was identified as a peak-X family of impurities. Subsequent analyses identified peak X impurities in some commercially available 5-HTP samples, but no EMS cases have been clearly attributed to 5-HTP, and a 2004 toxicology review argued that the trace levels of peak X observed in 5-HTP samples did not provide a credible toxicological mechanism — a position broadly supported in the subsequent literature, though it is worth noting that some authors of that 2004 review had nutraceutical-industry affiliations.¹¹ The practical implication is that 5-HTP from reputable manufacturers with rigorous quality control has a strong safety record at studied doses, but the supplement category has historically been variable in quality.

Other safety notes. 5-HTP has not been adequately studied in pregnancy, breastfeeding, or in children and adolescents — it should not be used in those populations. Side effects most commonly reported at studied doses are gastrointestinal: nausea, mild diarrhoea, or stomach cramping, usually transient and dose-related.¹

How does 5-HTP fit into a broader mood-support strategy?

If you are considering 5-HTP for low mood, the most useful framing is "where does it sit in the hierarchy of evidence?" Compared with the interventions covered in our natural mood support guide, 5-HTP sits in the "suggestive" tier — promising, but with smaller and older evidence than aerobic exercise, Mediterranean-style diet, EPA-predominant omega-3, or mindfulness-based stress reduction. For an overall view of how serotonin, stress hormones, and emotional resilience interact, the mood and emotional wellbeing pillar guide is the broader reference.

For most adults experiencing mild, transient low mood, the higher-leverage moves are foundational: regular aerobic activity, a Mediterranean-style dietary pattern, sleep consistency, mindfulness practice, and social connection. 5-HTP can be considered as an adjunct rather than a first step — and only in the absence of any contraindication. When clinical-range depression is present, prescription treatment under medical supervision is the appropriate path, not self-directed supplementation. Both options can coexist with lifestyle work, but they should not coexist with each other without a prescriber's involvement.

Worth bearing in mind: the brain's serotonin system is one of several mood-relevant networks, alongside the noradrenergic, dopaminergic, GABAergic, and HPA stress-axis systems. Targeting any single neurotransmitter is a simplification of how mood is actually produced. The dietary, exercise, and gut-microbiome interventions covered elsewhere in our knowledge centre act across multiple systems at once, which is part of why their evidence bases tend to be more robust.

When should you speak to a GP rather than reach for 5-HTP?

5-HTP is a food supplement, not a treatment for a clinical condition, and it is not a substitute for professional help when professional help is what the situation needs. Speak to a GP rather than rely on 5-HTP or any other supplement if:

• Low mood has persisted for more than two weeks and is not improving with rest, exercise, and ordinary stress-management changes.
• Symptoms are interfering with work, relationships, sleep, appetite, or daily functioning.
• You are experiencing persistent anxiety, panic episodes, or significant insomnia.
• You have thoughts of self-harm or suicide. In this case, contact NHS 111, your GP urgently, or the Samaritans on 116 123.
• You are currently taking any prescription antidepressant, anti-anxiety medication, migraine medication, or mood stabiliser. 5-HTP should never be added to these without your prescriber's knowledge.
• You have a history of bipolar disorder, psychosis, or any condition where altering serotonergic activity could be problematic.

Natural approaches and clinical care work best together rather than as alternatives — NICE guidelines (NG222) recommend lifestyle measures alongside treatment for what is now termed less severe depression (covering subthreshold and mild presentations).

Supporting Your Brain Health with BrainSmart

BrainSmart's range of brain health supplements is formulated to support cognitive function, memory, focus, and mood through evidence-based ingredients at clinically studied dosages.

Explore our range:

• BrainSmart Ultra — Comprehensive brain support
• BrainSmart Focus — Concentration and mental clarity
• BrainSmart Memory — Memory and recall
• BrainSmart Mood — Emotional wellbeing and stress

Tom Kaplan

Brain Health Writer at BrainSmart

Tom Kaplan is a specialist health writer focused on cognitive health, brain nutrition, and evidence-based approaches to supporting mental performance across the lifespan. His work draws on peer-reviewed research across neuroscience, nutritional psychiatry, and cognitive psychology — translating complex clinical findings into clear, practical guidance that helps readers make informed decisions about their brain health. Read Full Bio →